News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A new laboratory method for distinguishing pathogens from harmless relatives has been developed by scientists in the US. The high-throughput technique will enable the quick identification of pathogens, which could be used for bioterror weapons.
Swiss custom manufacturing firm Lonza has entered into a joint venture with investment management company Bio*One Capital to built a $250m (€210m) large-scale mammalian cell culture plant in Singapore, underlying Lonza's confidence that demand for the...